These slides were presented at TEDxCluj 2018. They highlight a revolutionary new treatment for cancer that involves the use of genetic engineering and embryonic gene-editing. You can watch the presentation here: https://youtu.be/bT-0oGDJqyo

1. THE ULTIMATE CURE FOR CANCER

2. Engineered microorganisms
Stem cell transplants
Immunotherapy
Nanoparticles
Gene therapy

3. Immunotherapy
Gene therapy

4. IMMUNOTHERAPY
PROCEDURE
4
Collection
T-cells
Editing
T-cells
Injecting
Engineered T-cells

5. Immunotherapy
Gene therapy
$475,000
$373,000

6. Immunotherapy Ultimate therapy
$475,000 $475,000

7. DNA REPAIR MECHANISM
THE CELL
DNA
DNA REPAIR
PROTEINS

8. ENHANCED DNA REPAIR MECHANISM
CRISPR

9. 37 TRILLION CELLS
Source: Bianconi, Eva, et al. "An estimation of the
number of cells in the human body." Annals of human
biology 40.6 (2013): 463-471.

10. 37 TRILLION CELLS
8 CELLS

11. Hypertrophic
Cardiomyopathy
HIV
Resistance
Source:
Ma, H. et al. Nature
doi:10.1038 nature.2017.22382
Source:
Kang, X. et al. J. Assist.
doi: 10.1007/s10815-016-0710-8
Beta
Thalassemia
Source:
Puping Liang et al. Protein & Cell
doi: 10.1007/s13238-017-0475-6
May 2016
Aug 2017 Sep 2017

12. 37 TRILLION CELLS
8 CELLS
GENERATIONS

13. AFFORDABLE TECHNOLOGY
$10,000$15,000
IVF Gene editing Delivery
CRISPR Kit $1,500

14. EMBRYONIC UPGRADES
AFFORDABLE AND EFFICIENT
14
Enhancing
Our biology on molecular level
Boosting
Our biology on cellular level
Adopting
Traits of powerful creatures

15. 40%RADIATION RESISTANCE
Source:
Takuma. H et al. Nature Communications
doi:10.1038/ncomms12808
HUMAN CELLSTARDIGRADE DNA
Sep 2016

16. A FUTURE WITHOUT CANCER DRUGS
$107
BILLION
2015
Source: IMS Health, 2016
CANCER MEDICATION
GLOBAL SPENDING ON
$150
BILLION
2020

17. MAJOR CHALLENGES
17
BIOETHICS

18. MAJOR CHALLENGES
18
BIOETHICS BUSINESS
INTEREST

19. MAJOR CHALLENGES
19
BIOETHICS BUSINESS
INTEREST
LACK OF
AWARENESS

20. THE ULTIMATE CURE FOR CANCER